128740-12-5

Usage

Uses

Used in Pharmaceutical and Medicinal Chemistry:
5-Benzyl-octahydro-pyrrolo[3,4-b]pyrrole is used as a potential active pharmaceutical ingredient for its possible biological activity. Its unique molecular structure may contribute to the development of new drugs and therapeutic agents.
Used in Synthetic Chemistry Research:
In the field of synthetic chemistry, 5-benzyl-octahydro-pyrrolo[3,4-b]pyrrole is used as a subject of study for its complex molecular configuration. Researchers may explore its synthesis and modification to understand its properties and potential applications in creating new chemical entities.
Used in Organic Synthesis Research:
5-Benzyl-octahydro-pyrrolo[3,4-b]pyrrole is utilized in organic synthesis research to investigate its role in the formation of new organic compounds. Its unique ring system and functional groups may offer novel pathways for the synthesis of complex organic molecules.
Used in Chemical Compound Development:
In the development of new chemical compounds, 5-benzyl-octahydro-pyrrolo[3,4-b]pyrrole is used as a building block or a starting material. Its structural features can be leveraged to create innovative compounds with specific properties for various applications.
Used in Industrial Applications:
5-Benzyl-octahydro-pyrrolo[3,4-b]pyrrole may find use in various industrial applications due to its unique chemical properties. Its potential applications could range from material science to the development of new chemical processes or products.

Upstream product

• 1631-26-1 1-benzyl-1H-pyrrole-2,5-dione 
• 185693-02-1 hexahydropyrrolo[3,4-b]pyrrole-1-carboxylic acid tert-butyl ester 
• 100-52-7 benzaldehyde 
• 128740-11-4 5-benzyl-octahydropyrrolo [3,4-b]pyrrole-4,6-dione 

Relevant academic research and scientific papers

DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A BICYCLO MOIETY

The disclosure provides compounds having formula (I), wherein the substituents are as defined herein. The compounds are useful for modulating the dopamine D3 receptor and for treating conditions associated therewith, such as addictions, drug dependency, and psychiatric conditions.

SUBSTITUTED OXETANES AND THEIR USE AS INHIBITORS OF CATHEPSIN C

This invention relates to a compound of formula I and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. respiratory diseases.

SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

This invention relates to 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)- amides of formula (1) and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. respiratory diseases.

SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

This invention relates to 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid(benzyl-cyano-methyl)-amides of formula 1 and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. respiratory diseases.

7-(1-PYRROLIDINYL)-3-QUINOLONE-AND-NAPHTHYRIDONECARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS AND FEED ADDITIVES

7-(1-Pyrrolidinyl)-3-quinolone- and -naphthyridonecarboxylic acid derivatives as antibacterial agents and feed additives, of the formula in which X1 is halogen, X2 is hydrogen, halogen, amino or other radical, R1 is alkyl, cycloalkyl, optionally substituted phenyl or other radical, R2 is hydrogen, alkyl or a dioxolylmethyl radical, R 3 i s A is N, CH, C-halogen, or the like, or forms a bridge with R1, and addition products thereof